| Wissenschaftl. Titel | Phase 1/2a, First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BNT411 as a Monotherapy in Patients With Solid Tumors and in Combination With Atezolizumab, Carboplatin and Etoposide in Patients With Chemotherapy-naïve Extensive-stage Small Cell Lung Cancer (ES-SCLC) |
| Erkrankung |
Thorax:
Nicht-kleinzelliges Lungenkarzinom:
Erstlinie
Solide Tumore/Neoplasien: Verschiedene solide Tumore/Neoplasien: Alle Linien |
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (K) Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) |
erstellt 28.07.2021 Data entry IX CCP
geändert 29.12.2023 Data entry III CCP